RMTI Market Analysis
Wall Street coverage
third-party contextWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- 59.17
- PEG ratio
- 4.43
- P/B
- 0.79
- P/S (TTM)
- 0.42
- EV/EBITDA
- 30.21
Profitability & growth
- ROE (TTM)
- -16.0%
- Operating margin
- -8.5%
- Revenue growth YoY
- -8.3%
- Dividend yield
- —
- Beta
- 1.61
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Rockwell Medical Inc
Company profileRockwell Medical, Inc. is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with iron deficiency treatment and hemodialysis products and therapies in the United States and internationally. The company is headquartered in Wixom, Michigan.
Classification
- Sector
- Healthcare
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 30142 SOUTH WIXOM ROAD, WIXOM, MI
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
